Want to see BCAX full AI Analyst Report?
Pembrolizumab (Keytruda®), Ficerafusp Alfa
Metastatic Head And Neck Squamous Cell Carcinoma, Recurrent Head And Neck Squamous Cell Carcinoma
Phase II/III
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Jan 10, 2025
―
Pembrolizumab, Bca101
Epithelial Ovarian Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma, Pancreas Cancer, Head And Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma Of Head And Neck, Head And Neck Neoplasms, Squamous Cell Carcinoma Of Anal Canal, Squamous Cell Carcinoma Of The Lung, Egfr Amplification, Carcinoma, Squamous Cell
Phase I
Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Jun 10, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Bicara Therapeutics Inc. (BCAX) have in its pipeline
BCAX is currently developing the following drugs: Pembrolizumab (Keytruda®), Ficerafusp Alfa, Pembrolizumab, Bca101. These drug candidates are in various stages of clinical development as the company works toward FDA approval.